obesity drug news today glp-1 october 21 2025 The popularity of drugs has exploded. Once a relatively obscure class of drugs prescribed for people with diabetes, GLP-1s have now shown an impressive ability to treat obesity, which affects Patient Behavior: How Does Price

Receptor-mediated activation of gastric vagal afferents by glucagonlike peptide1 in the rat

Novel role of CXCL14 in modulating STAR expression in luteinized granulosa cells: implication for progesterone synthesis in PCOS patients

By lowering LDL cholesterolpossibly through direct glucagon effects on the liver and LDL receptorsit holds promise not only for weight management but also for reducing cardiovascular disease risk at its root

Oral drops may be easier for some people to take and start working more quickly under the tongue compared to tablet forms that must travel through the digestive system

PMID: 40445127

Who Benefits Most from GLP-1